ANTIOS THERAPEUTICS
Antios Therapeutics is a biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its oral drug candidate for potentially curative treatment of HBV infections. Antios Therapeutics was founded by Abel De La Rosa, Douglas Mayers, and Idean Marvasty.
ANTIOS THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2018-01-01
Address:
Atlanta, Georgia, United States
Country:
United States
Website Url:
http://www.antiostherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
200.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx Sitelinks Search Box
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Ocera Therapeutics
Ocera Therapeutics is a biopharmaceutical company developing novel therapeutics for patients with acute and chronic liver diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Silverback Therapeutics
Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
EPIQ Capital Group
EPIQ Capital Group investment in Series B - Antios Therapeutics
Altium Capital
Altium Capital investment in Series B - Antios Therapeutics
Domain Associates
Domain Associates investment in Series B - Antios Therapeutics
Heartland Healthcare Capital
Heartland Healthcare Capital investment in Series B - Antios Therapeutics
Pontifax
Pontifax investment in Series B - Antios Therapeutics
GRA Venture Fund, LLC
GRA Venture Fund, LLC investment in Series B - Antios Therapeutics
GordonMD Global Investments
GordonMD Global Investments investment in Series B - Antios Therapeutics
Avego Bioscience Capital
Avego Bioscience Capital investment in Series B - Antios Therapeutics
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Series B - Antios Therapeutics
Amzak Health Investors
Amzak Health Investors investment in Series B - Antios Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-08-10 | Antios Therapeutics Appoints Catherine Coffey Ross as VP, Medical Affairs |
Official Site Inspections
http://www.antiostherapeutics.com Semrush global rank: 5.79 M Semrush visits lastest month: 1.44 K
- Host name: 208.82.16.57
- IP address: 208.82.16.57
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
